These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 35864302)

  • 1. Efficacy and Safety of a Fixed-Dose Combination of Cinnarizine 20 mg and Dimenhydrinate 40 mg in the Treatment of Patients with Vestibular Vertigo: An Individual Patient Data Meta-Analysis of Randomised, Double-Blind, Controlled Clinical Trials.
    Scholtz AW; Waldfahrer F; Hampel R; Weisshaar G
    Clin Drug Investig; 2022 Sep; 42(9):705-720. PubMed ID: 35864302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and Safety of a Fixed Combination of Cinnarizine 20 mg and Dimenhydrinate 40 mg vs Betahistine Dihydrochloride 16 mg in Patients with Peripheral Vestibular Vertigo: A Prospective, Multinational, Multicenter, Double-Blind, Randomized, Non-inferiority Clinical Trial.
    Scholtz AW; Hahn A; Stefflova B; Medzhidieva D; Ryazantsev SV; Paschinin A; Kunelskaya N; Schumacher K; Weisshaar G
    Clin Drug Investig; 2019 Nov; 39(11):1045-1056. PubMed ID: 31571128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and tolerability of a fixed low-dose combination of cinnarizine and dimenhydrinate in the treatment of vertigo: a 4-week, randomized, double-blind, active- and placebo-controlled, parallel-group, outpatient study.
    Pytel J; Nagy G; Tóth A; Spellenberg S; Schwarz M; Répassy G
    Clin Ther; 2007 Jan; 29(1):84-98. PubMed ID: 17379049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of cinnarizine/dimenhydrinate fixed combination with the respective monotherapies for vertigo of various origins: a randomized, double-blind, active-controlled, multicentre study.
    Hahn A; Novotný M; Shotekov PM; Cirek Z; Bognar-Steinberg I; Baumann W
    Clin Drug Investig; 2011; 31(6):371-83. PubMed ID: 21401214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the therapeutic efficacy of a fixed low-dose combination of cinnarizine and dimenhydrinate with betahistine in vestibular neuritis: a randomized, double-blind, non-inferiority study.
    Scholtz AW; Steindl R; Burchardi N; Bognar-Steinberg I; Baumann W
    Clin Drug Investig; 2012 Jun; 32(6):387-99. PubMed ID: 22506537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A fixed combination of cinnarizine/dimenhydrinate for the treatment of patients with acute vertigo due to vestibular disorders : a randomized, reference-controlled clinical study.
    Hahn A; Sejna I; Stefflova B; Schwarz M; Baumann W
    Clin Drug Investig; 2008; 28(2):89-99. PubMed ID: 18211117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and Tolerability of a Fixed Combination of Cinnarizine and Dimenhydrinate versus Betahistine in the Treatment of Otogenic Vertigo : A Double-Blind, Randomised Clinical Study.
    Cirek Z; Schwarz M; Baumann W; Novotny M
    Clin Drug Investig; 2005; 25(6):377-89. PubMed ID: 17532678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of vertigo due to acute unilateral vestibular loss with a fixed combination of cinnarizine and dimenhydrinate: a double-blind, randomized, parallel-group clinical study.
    Scholtz AW; Schwarz M; Baumann W; Kleinfeldt D; Scholtz HJ
    Clin Ther; 2004 Jun; 26(6):866-77. PubMed ID: 15262457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of vertebrobasilar insufficiency--associated vertigo with a fixed combination of cinnarizine and dimenhydrinate.
    Otto V; Fischer B; Schwarz M; Baumann W; Preibisch-Effenberger R
    Int Tinnitus J; 2008; 14(1):57-67. PubMed ID: 18616088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fixed combination of cinnarizine and dimenhydrinate versus betahistine dimesylate in the treatment of Ménière's disease: a randomized, double-blind, parallel group clinical study.
    Novotný M; Kostrica R
    Int Tinnitus J; 2002; 8(2):115-23. PubMed ID: 14763223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and Pharmacological Appropriateness of Cinnarizine and Dimenhydrinate in the Treatment of Vertigo and Related Symptoms.
    Plescia F; Salvago P; Dispenza F; Messina G; Cannizzaro E; Martines F
    Int J Environ Res Public Health; 2021 Apr; 18(9):. PubMed ID: 33946152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cinnarizine and dimenhydrinate in the treatment of vertigo in medical practice.
    Scholtz AW; Ilgner J; Loader B; Pritschow BW; Weisshaar G
    Wien Klin Wochenschr; 2016 May; 128(9-10):341-7. PubMed ID: 26659910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cinnarizine/betahistine combination vs. the respective monotherapies in acute peripheral vertigo: a randomized triple-blind placebo-controlled trial.
    Asadi P; Zia Ziabari SM; Majdi A; Vatanparast K; Naseri Alavi SA
    Eur J Clin Pharmacol; 2019 Nov; 75(11):1513-1519. PubMed ID: 31420703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of 3 antivertiginous medications on the vigilance of healthy volunteers.
    Schneider D; Kiessling B; Wieczorek M; Bognar-Steinberg I; Schneider L; Claussen CF
    Int J Clin Pharmacol Ther; 2003 Apr; 41(4):171-81. PubMed ID: 12708605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A double-blind crossover study comparing betahistine and cinnarizine in the treatment of recurrent vertigo in patients in general practice.
    Deering RB; Prescott P; Simmons RL; Downey LJ
    Curr Med Res Opin; 1986; 10(4):209-14. PubMed ID: 3780284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of vertigo with a homeopathic complex remedy compared with usual treatments: a meta-analysis of clinical trials.
    Schneider B; Klein P; Weiser M
    Arzneimittelforschung; 2005; 55(1):23-9. PubMed ID: 15727161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of an antivertiginous combination preparation of cinnarizine and dimenhydrinate on event-related potentials, reaction time and psychomotor performance--a randomized, double-blind, 3-way crossover study in healthy volunteers.
    Philipova D; Tzenova B; Iwanowitsch A; Bognar-Steinberg I
    Int J Clin Pharmacol Ther; 2004 Apr; 42(4):218-31. PubMed ID: 15124980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Challenges of Studying Peripheral Vestibular Vertigo.
    Naples JG
    Clin Drug Investig; 2020 Jan; 40(1):99-100. PubMed ID: 31676932
    [No Abstract]   [Full Text] [Related]  

  • 19. [Treatment costs of otogenic vertigo].
    Stratmann L; Heinen-Kammerer T; Motzkat-Gniss K; Holtmannspötter C; Rychlik R
    Med Klin (Munich); 2006 Nov; 101(11):886-90. PubMed ID: 17235475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Authors' Reply to "The Challenges of Studying Peripheral Vestibular Vertigo".
    Scholtz AW; Weisshaar G
    Clin Drug Investig; 2020 Jan; 40(1):101-102. PubMed ID: 31679119
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.